Journals / Pamukkale Tıp Dergisi / 2020 / Cilt: 13 - Sayı: 3

The evaluation of serum Pancreatic-derived factor and Malondialdehyde levels in patients with polycystic ovary syndrome

Polikistik over sendrom'lu hastalarda Pancreatic Derived Factor ve Malondialdehit düzeylerinin incelenmesi

Pages
715–721
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: These outcomes showed that PANDER level is not related with insulin resistance, ovarian hyperandrogenism and oxidative stress in PCOS.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: Alterations in β-cell function may play crucial roles in the pathogenesis of polycystic ovary syndrome (PCOS).
📊
Key Findings & Data:Materials and methods: Twenty-seven patients with PCOS and 24 healthy control women were evaluated in this controlled clinical study.
💡
Conclusion & Impact:Conclusion: These outcomes showed that PANDER level is not related with insulin resistance, ovarian hyperandrogenism and oxidative stress in PCOS.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: Alterations in β-cell function may play crucial roles in the pathogenesis of polycystic ovary syndrome (PCOS). Pancreatic-derived factor (PANDER) is a cytokine-like protein, inducing of pancreatic β-cell apoptosis under pathological conditions. This investigation was planned to determine serum PANDER levels and establish whether serum PANDER levels are related with oxidative stress, and insulin resistance in PCOS. Materials and methods: Twenty-seven patients with PCOS and 24 healthy control women were evaluated in this controlled clinical study. Serum lipid sub-fractions, fasting glucose, insulin, gonadotropins, androgens, malondialdehyde (MDA) and PANDER levels were measured. Homeostasis model assessment (HOMA-IR) were used to estimate insulin resistance. Results: Subjects in study and control groups were similar with respect to waist measurements, gonadotropins, lipid sub-fractions, MDA and PANDER levels, the women with PCOS had considerably higher FAI and HOMA-IR than healthy women. Serum PANDER levels were not correlated with any studied parameters. Conclusion: These outcomes showed that PANDER level is not related with insulin resistance, ovarian hyperandrogenism and oxidative stress in PCOS.

Özet

Amaç: β hücrelerinin fonksiyonlarındaki değişiklikler polikistik over sendromunun (PCOS) patogenezinde önemli roller oynayabilir. Pankreatic Derived Factor (PANDER), patolojik koşullar altında pankreatik β hücre apoptozunu indükleyen sitokin benzeri bir proteindir. Bu araştırma, serum PANDER düzeylerini belirlemek ve serum PANDER düzeylerinin oksidatif stres ve PCOS'taki insülin direnci ile ilişkili olup olmadığını belirlemek için planlanmıştır. Gereç ve yöntem: Bu kontrollü klinik çalışmada PKOS tanısı almış 27 hasta ve 24 sağlıklı kadın kontrol grubu olarak değerlendirildi. Serum lipit alt fraksiyonları, açlık glikozu, insülin, gonadotropinler ve androjenler, malondialdehit (MDA) ve PANDER düzeyleri ölçüldü. İnsülin direncini tahmin etmek için homeostaz model değerlendirmesi (HOMA-IR) kullanıldı. Bulgular: Çalışma ve kontrol grubundaki denekler bel ölçümleri, gonadotropinler, lipit alt fraksiyonları, MDA ve PANDER düzeyleri açısından benzerdi, PKOS'lu kadınlar sağlıklı kadınlardan önemli ölçüde daha yüksek FAI ve HOMA-IR'ye sahipti. Serum PANDER düzeyleri çalışılan parametrelerle ilişkili değildi. Sonuç: Bu sonuçlar PANDER seviyesinin PCOS'ta insülin direnci, over kaynaklı hiperandrojenizm ve oksidatif stres ile ilişkili olmadığını göstermiştir.

🔖

Cite This Article

Demir, S., Kaleli, İ., Kaleli, M. B., Çabuş, Ü., Fenkci, V. (2022). The evaluation of serum Pancreatic-derived factor and Malondialdehyde levels in patients with polycystic ovary syndrome. Pamukkale Tıp Dergisi, Cilt: 13 - Sayı: 3, 715–721. https://ajindex.com/articles/587124

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Ehrmann DA. Medical progress: polycystic ovary syndrome. N Engl J Med 2005;352:1223-1236. https:// doi.org/10.1056/NEJMra041536 Broekmans FJ, Knauff EAH, Valkenburg O, Laven JS, Eijkemans MJ, Fauser BCJM. PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG 2006;113:1210-1217. https:// doi.org/10.1111/j.1471-0528.2006.01008.x Teede HJ, Misso ML, Costello MF, et al. Recommendations from the international evidencebased guideline for the assessment and management of polycstic ovary syndrome. Hum Reprod 2018;33:1602- 1618. https://doi.org/10.1093/humrep/dey256
  2. Artimani T, Karimi J, Mehdizadeh M, et al. Evaluation of pro-oxidant-antioxidant balance (PAB) and its association with inflammatory cytokines in polycystic ovary syndrome (PCOS). Gynecol Endocrinol 2018;34:148-152. https://doi.org/10.1080/09513590.2 017.1371691 Mohammadi S, Kayedpoor P, Karimzadeh Bardei L, Nabiuni M. The effect of curcumin on TNF-α, IL-6 and CRP expression in a model of polycystic ovary syndrome as an inflammation state. J Reprod Infertil 2017;18:352-360. Amer SAK. Polycystic ovarian syndrome: diagnosis and management of related infertility. Obstet Gynaecol Reprod Med 2009;19:263-270. https://doi. org/10.1016/j.ogrm.2009.06.006 González F. Inflammation in polycystic ovary syndrome: underpinning of insulin resistance and ovarian dysfunction. Steroids 2012;77:300-305. https:// doi.org/10.1016/j.steroids.2011.12.003 Zhu Y, Xu G, Patel A, et al. Cloning, expression and initial characterization of a novel cytokine like gene family. Genomics 2002;80:144-150. https://doi. org/10.1006/geno.2002.6816 Cao X, Gao Z, Robert CE, et al. Pancreatic-derived factor (FAM3B), a novel islet cytokine, induces apoptosis of insulin-secreting beta-cells. Diabetes 2003;52:2296- 2303. https://doi.org/10.2337/diabetes.52.9.2296
  3. Burkhardt BR, Greene SR, White P, et al. PANDERinduced cell-death genetic networks in islets reveal central role for caspase-3 and cyclin-dependent kinase inhibitor 1A (p21) Gene 2006;369:134-141. https://doi. org/10.1016/j.gene.2005.10.040 Fenkci V, Fenkci S, Yilmazer M, Serteser M. Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease. Fertil Steril 2003;80:123-127. https://doi.org/10.1016/s0015- 0282(03)00571-5
  4. Chen L, Xu WM, Zhang D. Association of abdominal obesity, insulin resistance, and ox